During VEGF inhibitors therapy, arrhythmias can be related mainly to QT interval prolongation, but cardiac ischemia, myocardial dysfunction and predisposing factors may be incriminated [3,4,5]. Here, VEGFA is linked to cardiac arrhythmia.